Robotic Reoperative Anti‐reflux Surgery: Low Perioperative Morbidity and High Symptom Resolution

Elmously, Adham; Gray, Katherine D.; Ullmann, Timothy M.; Fahey, Thomas J.; Afaneh, Cheguevara; Zarnegar, Rasa

doi:10.1007/s00268-018-4708-5

Cited by 17 publications

(7 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to our findings, Elmously et al in 2018 reported a retrospective review of 200 patients (162 primary anti-reflux surgery and 38 reoperative surgery), concluding that the robotic approach leads to very low morbidity, short length of stay, and excellent functional outcomes in patients undergoing reoperative surgery when compared to patients undergoing primary anti-reflux surgery [ 13 ]. Furthermore, Elmously et al demonstrated that patients who underwent robotic redo surgery experienced complete or partial benefits from preoperative symptoms and more than 80% not require a daily PPI use [ 13 ].…”

Section: Discussionmentioning

confidence: 64%

“…Minimally invasive approach, which is the actual standard surgical approach for many complex surgical procedures [ 10 – 12 ], has also showed its benefit in the redo anti-reflux surgery. However, the conversion rate to open surgery is higher when compared to primary surgery, furthermore the robotic approach is described only in few cases [ 13 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Robotic revision surgery after failed Nissen anti-reflux surgery: a single center experience and a literature review

et al. 2023

View full text Add to dashboard Cite

Background The gastroesophageal reflux disease (GERD) worldwide prevalence is increasing maybe due to population aging and the obesity epidemic. Nissen fundoplication is the most common surgical procedure for GERD with a failure rate of approximately 20% which might require a redo surgery. The aim of this study was to evaluate the short- and long-term outcomes of robotic redo procedures after anti-reflux surgery failure including a narrative review. Methods We reviewed our 15-year experience from 2005 to 2020 including 317 procedures, 306 for primary, and 11 for revisional surgery. Results Patients included in the redo series underwent primary Nissen fundoplication with a mean age of 57.6 years (range, 43–71). All procedures were minimally invasive and no conversion to open surgery was registered. The meshes were used in five (45.45%) patients. The mean operative time was 147 min (range, 110–225) and the mean hospital stay was 3.2 days (range, 2–7). At a mean follow-up of 78 months (range, 18–192), one patient suffered for persistent dysphagia and one for delayed gastric emptying. We had two (18.19%) Clavien–Dindo grade IIIa complications, consisting of postoperative pneumothoraxes treated with chest drainage. Conclusion Redo anti-reflux surgery is indicated in selected patients and the robotic approach is safe when it is performed in specialized centers, considering its surgical technical difficulty.

show abstract

Section: Discussionmentioning

confidence: 64%

Section: Introductionmentioning

confidence: 99%

Robotic revision surgery after failed Nissen anti-reflux surgery: a single center experience and a literature review

et al. 2023

View full text Add to dashboard Cite

show abstract

“…While robotic anti-reflux surgery has demonstrated postoperative outcomes comparable with the laparoscopic approach, some small studies have shown improved outcomes in cases of complex reoperative antireflux surgery with the robotic approach over the laparoscopic approach. Specifically, robotic-assisted reoperative anti-reflux operations have been associated with lower conversion rates, lower perforation and vagal nerve injury rates, lower readmission rates and decreased length of stay, as well as superior symptomatic relief and improved functional outcomes (22)(23)(24).…”

Section: Transitioning To a Robotic Thoracic Program: Why Do It?mentioning

confidence: 99%

Transitioning to robotics in a successful thoracoscopic and laparoscopic thoracic program: why do it, and how?

Yousef¹,

Luketich²,

Sarkaria³

2023

J Vis Surg

View full text Add to dashboard Cite

Background: the rise of robotics in thoracic surgeryThe robotic surgical platform has been embraced with impressive speed over the past few decades, despite initial skepticism from many surgeons. Computer Motion's initial robot, "Zeus", while a revolution in its time, had many limitations, particularly in articulation. This limited the utility of the robotic platform in complex operations and fueled early skepticism. However, while "Zeus" was approved for a limited number of clinical trials, Computer Motion's competitor, Intuitive Surgical, was soon to release their robotic platform, with several key technologic advances. The two companies merged in 2003 leading to overall improved technology. Intuitive Surgical's "Davinci" system emerged as the clinical forerunner for nearly two decades as more advanced versions of the platform were introduced. The skills required to complete complex cases with the Davinci were soon acquired by an increasing number of surgeons, and, today, robotic-assisted surgery with the Davinci has become the new "norm" in many centers.The robotic platform has been utilized in thoracic surgery for over 20 years, with one of the first reported

show abstract

“… 1 , 2 , 3 , 4 Although laparoscopy remains the most commonly used surgical approach, robotic surgery has proven to be a safe minimally invasive approach with potential surgical advantages and excellent functional outcomes. 5 …”

Section: Introductionmentioning

confidence: 99%

Robotic single port anti‐reflux surgery: Initial worldwide experience of two cases with a novel surgical approach to treat gastroesophageal reflux disease

Cubisino

Dreifuss

Schlottmann

et al. 2022

Robotics Computer Surgery

View full text Add to dashboard Cite

Introduction To date, no anti‐reflux operations have been reported with the new da Vinci Single‐Port (single port (SP)) robotic platform. We aimed to describe this novel surgical approach and evaluate its safety and feasibility. Methods All robotic SP operations were performed under an Institutional Review Board approved protocol. Results Two patients underwent robotic SP anti‐reflux surgery through a single incision of 2.7 cm (one Nissen‐fundoplication and one re‐Redo Nissen‐fundoplication). The mean docking‐time was 2.5 (2–3) minutes and mean console‐time was 147 (119–155) minutes. No additional ports were needed, and no intraoperative complications occurred. Patients tolerated a soft diet on postoperative day 1 and were discharged on POD‐2 and 3. Conclusion Robotic SP anti‐reflux surgery appears to be safe and feasible. This platform offers similar advantages to the multiport robotic surgery, while adding lower invasiveness and an improved cosmesis. Further studies are needed to confirm our results and evaluate long‐term outcomes of this surgical approach.

show abstract

Robotic Reoperative Anti‐reflux Surgery: Low Perioperative Morbidity and High Symptom Resolution

Abstract: The robotic approach allows for minimal morbidity, short length of stay, and excellent functional outcomes in patients undergoing reoperative ARS when compared to patients undergoing primary ARS.

Cited by 17 publications

References 38 publications

Robotic revision surgery after failed Nissen anti-reflux surgery: a single center experience and a literature review

Robotic revision surgery after failed Nissen anti-reflux surgery: a single center experience and a literature review

Transitioning to robotics in a successful thoracoscopic and laparoscopic thoracic program: why do it, and how?

Robotic single port anti‐reflux surgery: Initial worldwide experience of two cases with a novel surgical approach to treat gastroesophageal reflux disease

Contact Info

Product

Resources

About